申请人:ADAERATA, LIMITED PARTNERSHIP
公开号:US20160031935A1
公开(公告)日:2016-02-04
A compound of Formula (I): or a pharmaceutically acceptable salt, hydrate, solvate, or racemic mixture or stereoisomer thereof, and methods for preventing or treating an LDL-cholesterol-related disease or disorder using such compound(s), and kits and compositions comprising such compound(s).
公式(I)的化合物:或其药用可接受的盐、水合物、溶剂合物、或其拉克米混合物或立体异构体,以及使用这种化合物预防或治疗LDL胆固醇相关疾病或紊乱的方法,以及包含这种化合物的试剂盒和组合物。